...
首页> 外文期刊>Journal of neuroinflammation >Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology
【24h】

Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology

机译:补体激活片段C5a受体CD88和C5L2与神经原纤维病理相关

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Alzheimer’s disease (AD) is a neurodegenerative dementia characterized by the decline of cognition and the presence of neuropathological changes including neuronal loss, neurofibrillary pathology and extracellular senile plaques. A neuroinflammatory process is also triggered and complement activation has been hypothesized to have a relevant role in this local inflammatory response. C5a, a proinflammatory anaphylatoxin generated after complement activation, exerts its chemotactic and inflammatory functions through the CD88 receptor while the more recently discovered C5L2 receptor has been postulated to have an anti-inflammatory role. Previously, we reported that a CD88 specific antagonist (PMX205) decreased the pathology and improved cognition in transgenic models of AD suggesting that C5a/C5aR interaction has an important role in the progression of the disease. Methods The present study characterizes the expression of the two receptors for C5a in human brain with confirmed post mortem diagnosis of vascular dementia (VD) or AD as well as age matched controls by immunohistochemistry and Western blot analysis using several antibodies against different epitopes of the human receptors. Results The CD88 and C5L2 antibodies revealed increased expression of both receptors in AD samples as compared to age-matched controls or VD brain tissue by Western blot and immunohistochemistry, using multiple antibodies and distinct cohorts of brain tissue. Immunostaining showed that both the C5L2 and CD88 antibodies similarly labeled abundant neurofibrillary tangles, neuropil threads and dystrophic neurites associated with plaques in the hippocampus and frontal cortex of AD cases. In contrast, little or no neuronal staining, tangles or dystrophic neurites associated with plaques were observed in control or VD brains. CD88 and C5L2 receptors are associated with both early (AT8) and mature (PHF1) neurofibrillary tangles and can be found either independently or colocalized with each other. Conclusions The observed association of CD88 and C5L2 with neurofibrillary pathology suggests a common altered pathway of degradation.
机译:背景阿尔茨海默氏病(AD)是一种神经退行性痴呆,其特征在于认知能力下降和神经病理变化的存在,包括神经元丢失,神经原纤维病理和细胞外老年斑。还触发了神经炎症过程,并假设补体激活在这种局部炎症反应中具有相关作用。 C5a是补体激活后产生的促炎性过敏毒素,它通过CD88受体发挥其趋化和炎症功能,而最近发现的C5L2受体则被认为具有抗炎作用。以前,我们报道了CD88特异性拮抗剂(PMX205)可以降低AD转基因模型的病理状况并改善其认知能力,这表明C5a / C5aR相互作用在该疾病的进展中具有重要作用。方法本研究通过免疫组化和Western blot分析,使用几种针对人类不同表位的抗体,通过免疫组化和Western印迹分析来表征人脑中C5a的两种受体的表达,这些结果已被证实为死后诊断为血管性痴呆(VD)或AD以及年龄匹配的对照。受体。结果与年龄匹配的对照或VD脑组织相比,CD88和C5L2抗体通过多种抗体和不同的脑组织队列,与年龄匹配的对照或VD脑组织相比,显示出两种受体的表达均增加。免疫染色显示,C5L2和CD88抗体都相似地标记了AD病例海马和额叶皮质斑块相关的丰富的神经原纤维缠结,神经毛线和营养不良的神经突。相比之下,在对照或VD脑中几乎没有观察到与斑块相关的神经元染色,缠结或营养不良的神经突。 CD88和C5L2受体与早期(AT8)和成熟(PHF1)神经原纤维缠结相关,并且可以独立存在或彼此共存。结论观察到的CD88和C5L2与神经原纤维病理的相关性提示了降解的常见途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号